Alex Morgan is a Principal on the investment team at Khosla Ventures, with a special focus on biotechnology, healthcare, data science, and AI/ML. With over five billion dollars under management, the firm focuses on a broad range of areas including consumer, enterprise, education, advertising, financial services, semiconductors, health, big data, agriculture/food, sustainable energy, and robotics. Investments include Atrendex, BioAge, Bionaut, Cellino, Deep Genomics, DiscernDx, Docbot, Ellipsis, Faeth, Flow Neuroscience, Hello Heart, Karius, Loop Genomics, Nebula Genomics, Oncobox, Overture, Prellis, Probably Genetic, Q Bio, StimScience, Syllable Corporation, Vitro Labs. As a scientist, he has published over 50 scientific publications, primarily at the intersection of computer science, biology, and healthcare. As an inventor, he has licensed IP to three separate companies. As an entrepreneur, he has worked as an early employee or co-founder at a range of startups, including Personalis, DigiSight, Stimulomics, and Opal Financial.
Over the past decade, almost US$2 billion has been invested in human microbiome research. Major projects are under way in the United States, the European Union, China, Canada, Ireland, South Korea and Japan. This session will provide the biotech and life sciences VC community perspective.